Campone M, De Laurentiis M, Zamagni C, Kudryavcev I, et al. Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial. Breast Cancer Res Treat 2022 Feb 25. pii: 10.1007/s10549-022-06543.
PMID: 35212906